Effects of Axonal Ion Channel Dysfunction on Quality of Life in Type 2 Diabetes

OBJECTIVE: Pharmacological agents for diabetic peripheral neuropathy (DN) target a number of mechanisms, including sodium channel function and γ-aminobutyric acid–minergic processes. At present, prescription is undertaken on a trial-and-error basis, leading to prolonged medication trials and greater...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwai, Natalie C.G., Arnold, Ria, Wickremaarachchi, Chathupa, Lin, Cindy S.-Y., Poynten, Ann M., Kiernan, Matthew C., Krishnan, Arun V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631837/
https://www.ncbi.nlm.nih.gov/pubmed/23404298
http://dx.doi.org/10.2337/dc12-1310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631837/
https://www.ncbi.nlm.nih.gov/pubmed/23404298
http://dx.doi.org/10.2337/dc12-1310

Ejemplares similares